| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome
|
Jacobsen, E.D.
|
|
|
22 |
7 |
p. 1608-1613
|
artikel
|
| 2 |
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
|
Vollebergh, M.A.
|
|
|
22 |
7 |
p. 1561-1570
|
artikel
|
| 3 |
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma
|
Witzig, T.E.
|
|
|
22 |
7 |
p. 1622-1627
|
artikel
|
| 4 |
Anthracycline-induced cardiomyopathy in siblings with early breast cancer
|
Young, A.C.
|
|
|
22 |
7 |
p. 1692
|
artikel
|
| 5 |
A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score
|
Jiang, W.
|
|
|
22 |
7 |
p. 1644-1652
|
artikel
|
| 6 |
Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects
|
Raijmakers, N.J.H.
|
|
|
22 |
7 |
p. 1478-1486
|
artikel
|
| 7 |
Biomarkers and efficacy: are we nearly there yet?
|
Russo, A.
|
|
|
22 |
7 |
p. 1469-1470
|
artikel
|
| 8 |
CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab
|
Miyazaki, K.
|
|
|
22 |
7 |
p. 1601-1607
|
artikel
|
| 9 |
Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival
|
Heitz, F.
|
|
|
22 |
7 |
p. 1571-1581
|
artikel
|
| 10 |
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973–2004): the potential role of health care
|
Lyratzopoulos, G.
|
|
|
22 |
7 |
p. 1661-1666
|
artikel
|
| 11 |
Clinical relevance of TNM staging system according to breast cancer subtypes
|
Park, Y.H.
|
|
|
22 |
7 |
p. 1554-1560
|
artikel
|
| 12 |
Correction to: EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer
|
|
|
|
22 |
7 |
p. 1693
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
22 |
7 |
p. ii-iii
|
artikel
|
| 14 |
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
|
Bokemeyer, C.
|
|
|
22 |
7 |
p. 1535-1546
|
artikel
|
| 15 |
Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma
|
Yi, J.H.
|
|
|
22 |
7 |
p. 1636-1643
|
artikel
|
| 16 |
Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies
|
Pelucchi, C.
|
|
|
22 |
7 |
p. 1487-1499
|
artikel
|
| 17 |
Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma
|
Kluin-Nelemans, H.C.
|
|
|
22 |
7 |
p. 1595-1600
|
artikel
|
| 18 |
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy
|
Felip, E.
|
|
|
22 |
7 |
p. 1507-1519
|
artikel
|
| 19 |
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
|
Thiel, U.
|
|
|
22 |
7 |
p. 1614-1621
|
artikel
|
| 20 |
Pancreatic cancer treatment and research: an international expert panel discussion
|
Tempero, M.A.
|
|
|
22 |
7 |
p. 1500-1506
|
artikel
|
| 21 |
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1
|
Danson, S.J.
|
|
|
22 |
7 |
p. 1653-1660
|
artikel
|
| 22 |
Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting
|
Rouzier, R.
|
|
|
22 |
7 |
p. 1582-1587
|
artikel
|
| 23 |
Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution
|
Gronchi, A.
|
|
|
22 |
7 |
p. 1675-1681
|
artikel
|
| 24 |
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients
|
Pagano, L.
|
|
|
22 |
7 |
p. 1628-1635
|
artikel
|
| 25 |
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study
|
Biesma, B.
|
|
|
22 |
7 |
p. 1520-1527
|
artikel
|
| 26 |
Reply to The sequence of cytoreductive nephrectomy: glass half empty or glass half full?
|
Escudier, B.
|
|
|
22 |
7 |
p. 1691-1692
|
artikel
|
| 27 |
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia
|
Feng, F.
|
|
|
22 |
7 |
p. 1588-1594
|
artikel
|
| 28 |
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
|
Egberts, F.
|
|
|
22 |
7 |
p. 1667-1674
|
artikel
|
| 29 |
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
|
Gridelli, C.
|
|
|
22 |
7 |
p. 1528-1534
|
artikel
|
| 30 |
Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment
|
Xiao, C.
|
|
|
22 |
7 |
p. 1547-1553
|
artikel
|
| 31 |
Stem-cell transplantation in T-cell non-Hodgkin’s lymphomas
|
Hosing, C.
|
|
|
22 |
7 |
p. 1471-1477
|
artikel
|
| 32 |
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
|
Stacchiotti, S.
|
|
|
22 |
7 |
p. 1682-1690
|
artikel
|
| 33 |
Table of Contents
|
|
|
|
22 |
7 |
p. iv-v
|
artikel
|
| 34 |
The sequence of cytoreductive nephrectomy: glass half empty or glass half full?
|
Bex, A.
|
|
|
22 |
7 |
p. 1691
|
artikel
|
Tijdschrift beschrijving